Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NSC624206

(Synonyms: NSC-624206, N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride) Copy Product Info
🥰Excellent

Synonyms: NSC-624206, N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride

Catalog No. T12265 Copy Product Info
🥰Excellent
NSC624206 (N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride) is an asymmetric disulfide small molecule that acts as a selective inhibitor of the ubiquitin-activating enzyme E1 (UBA1). It effectively blocks the in vitro ubiquitination-mediated degradation of the cell cycle regulator p27 and induces the accumulation of p27 protein in the HepG2 liver cancer cell model.
NSC624206
Cas No. 13116-77-3
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$77-In Stock
5 mg$297-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
NSC624206 (N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride) is an asymmetric disulfide small molecule that acts as a selective inhibitor of the ubiquitin-activating enzyme E1 (UBA1). It effectively blocks the in vitro ubiquitination-mediated degradation of the cell cycle regulator p27 and induces the accumulation of p27 protein in the HepG2 liver cancer cell model.
Targets & IC50
Ubiquitin E1:9 μM
In vitro
Method: Human hepatocellular carcinoma HepG2 cells were treated with NSC624206 (1-10 μM) for 24 h. Western blotting was performed to detect endogenous p27 protein expression levels.
Result: NSC624206 induced the accumulation of p27 protein in HepG2 cells in a dose-dependent manner [1].
Method: Mink lung epithelial Kip16 cells stably expressing GFP-p27 were treated with NSC624206 (1-10 μM) for 24 h. Fluorescence microscopy and Western blotting were used to detect GFP-p27 expression levels.
Result: NSC624206 treatment induced uniform and stable accumulation of GFP-p27 in Kip16 cells, with a significant increase in GFP-p27 levels observed at 1 μM [1].
Method: In vitro E1/E2 thioester formation reactions were assembled containing fluorescein-labeled ubiquitin, E1, E2, and ATP. NSC624206 (1-50 μM) was added, and the formation of E1-ubiquitin and E2-ubiquitin thioester adducts was detected by non-reducing SDS-PAGE.
Result: NSC624206 inhibited the formation of the E1-ubiquitin thioester bond with an IC50 of approximately 9 μM, without significantly affecting E2 activity [1].
SynonymsNSC-624206, N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride
Chemical Properties
Molecular Weight410.51
FormulaC19H33Cl2NS2
Cas No.13116-77-3
SmilesCl.ClC1=CC=C(C=C1)CSSCCNCCCCCCCCCC
Relative Density.no data available
Storage & Solubility Information
StorageKeep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: NSC624206 chemical structure | NSC624206 in vitro | NSC624206 formula | NSC624206 molecular weight